Leading Brokers Name 3 ASX Shares to Buy Today 28 April 2025
What Does Macquarie Think ResMed Shares Are Worth?
ResMed's Tariff Exemption Should Support Multiples -- Market Talk
Morgans Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
ResMed Price Target Cut 1.6% to A$48.00/Share by Macquarie
ResMed Inc. Files Quarterly Report, Reinforces Market Position
ResMed Inc: Form 10-Q for the Quarter Ended March 31, 2025
ResMed Inc's Earnings Call Highlights Growth and Innovation
ResMed Inc. Stock Advances 10.1%, Outperforms Market
Research Alert: CFRA Reiterates Buy Recommendation On Shares Of Resmed Inc.
S&P 500 Futures Fall In Premarket Trading; Texas Instruments, ServiceNow Lead
ResMed Inc To Go Ex-Dividend On May 7th, 2025 With 0.08282 AUD Dividend Per Share
Resmed Is Protected From Trump's Tariffs, Doesn't Plan to Raise Prices -- Interview
ResMed Price Target Raised 1.8% to A$45.60/Share by Barrenjoey
Express News | Resmed Inc : Piper Sandler Cuts Target Price to $248 From $260
ResMed Shares Jump 8% on Strong Q3 Update
Market Mover | ResMed Shares Surge Over 7% After Reporting Higher Fiscal Q3 Earnings and Revenue
ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript Summary
ResMed Inc Announces New Dividend Distribution for CDIs
ResMed Inc: Resmed Announces Results for the Third Quarter of FY2025